Cindol (Suspension) Instructions for Use
ATC Code
D02AB (Zinc preparations)
Active Substance
Zinc oxide (Ph.Eur. European Pharmacopoeia)
Clinical-Pharmacological Group
Drug with astringent and drying action for external use
Pharmacotherapeutic Group
Preparations with emollient and protective action. Zinc preparations
Pharmacological Action
Zinc oxide exerts a drying, adsorbent, astringent, and disinfectant action.
It reduces exudation and weeping, which alleviates local inflammation and irritation.
Indications
Diaper rash, intertrigo, miliaria, dermatitis, ulcerative skin lesions, superficial wounds, and burns.
ICD codes
| ICD-10 code | Indication |
| L20.8 | Other atopic dermatitis (neurodermatitis, eczema) |
| L22 | Diaper dermatitis |
| L23 | Allergic contact dermatitis |
| L24 | Irritant contact dermatitis |
| L25 | Unspecified contact dermatitis |
| L30.0 | Nummular eczema |
| L30.4 | Erythematous intertrigo |
| L30.9 | Dermatitis, unspecified |
| L74.3 | Unspecified miliaria |
| L89 | Decubitus ulcer and pressure area |
| L98.4 | Chronic skin ulcer, not elsewhere classified |
| T14.0 | Superficial injury of unspecified body region (including abrasion, bruise, contusion, hematoma, bite of nonvenomous insect) |
| T30 | Burns and corrosions of unspecified body region |
| ICD-11 code | Indication |
| 9A06.70 | Atopic eczema of the eyelids |
| EA40 | Tropical phagedenic ulcer |
| EA80.0 | Infantile atopic eczema |
| EA80.1 | Childhood atopic eczema |
| EA80.2 | Adult atopic eczema |
| EA80.Z | Atopic eczema, unspecified |
| EA82 | Nummular dermatitis |
| EA85.20 | Atopic hand eczema |
| EA85.2Z | Hand dermatitis, unspecified |
| EA85.3 | Foot dermatitis |
| EA89 | Generalized eczematous dermatitis of unspecified type |
| EA8Z | Dermatitis or eczema, unspecified |
| EF60 | Ischemic ulceration of the skin |
| EH40.10 | Diaper dermatitis |
| EH90.Z | Pressure ulcer of unspecified degree |
| EH92 | Dermatoses provoked by friction or mechanical impact |
| EH92.1 | Blister due to friction |
| EK00.Z | Allergic contact dermatitis, unspecified |
| EK02.20 | Intertriginous dermatitis due to friction, sweating or contact with body fluids |
| EK02.Z | Irritant contact dermatitis, unspecified |
| EK5Y | Other specified skin lesions provoked by exposure to external factors |
| EM0Z | Unspecified skin disorder |
| ME60.2 | Ulcerative skin lesion of unspecified nature |
| ND56.0 | Superficial injury of unspecified body region |
| NE11 | Burn of unspecified body region |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply a thin layer of the suspension to the affected skin areas.
Use two to four times daily, or as directed by a physician.
For diaper rash, apply at each diaper change, ensuring the skin is clean and dry before application.
For dermatitis, miliaria, or intertrigo, apply after cleansing the area and gently patting it dry.
For superficial wounds, burns, or ulcerative lesions, apply after appropriate wound cleansing and debridement.
The frequency of application may be adjusted based on the severity of the condition and the patient’s response.
Shake the bottle vigorously before each use to ensure a uniform suspension.
Application can be performed with a clean cotton pad or fingertips; wash hands thoroughly before and after use.
Avoid contact with eyes and mucous membranes. If contact occurs, rinse thoroughly with water.
Discontinue use and consult a physician if symptoms worsen or if no improvement is seen after several days of treatment.
Do not apply to extensive areas of broken skin or in cases of known hypersensitivity to zinc oxide.
Adverse Reactions
Allergic reactions such as skin itching, hyperemia, and skin rash are possible.
Contraindications
Hypersensitivity to zinc oxide.
Use in Pregnancy and Lactation
Use during pregnancy and breastfeeding is possible according to indications, in recommended doses.
Pediatric Use
Use in children is possible according to indications, in recommended doses and dosage forms.
Special Precautions
It is not recommended to use zinc oxide preparations in acute purulent-inflammatory diseases.
Avoid contact with the eyes.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Suspension for topical application 12.5%: fl. 100 g or 125 g, bot. 100 g or 125 g
Marketing Authorization Holder
Biopharmkombinat, LLC (Russia)
Dosage Form
 |
Cindol | Suspension for topical application 12.5%: fl. 100 g or 125 g, bot. 100 g or 125 g |
Dosage Form, Packaging, and Composition
Suspension for external use in the form of a heterogeneous suspension with a rapidly settling sediment of white or white with a grayish tint after shaking.
| 100 g | |
| Zinc oxide | 12.5 g |
Excipients: talc – 12.5 g, potato starch – 12.5 g, glycerol – 20 g, ethanol (ethyl alcohol) 70% – 20 g, purified water – up to 100 g.
100 g – bottles (1) – cardboard packs.
125 g – bottles (1) – cardboard packs.
100 g – bottles (1) – cardboard packs.
125 g – bottles (1) – cardboard packs.
Suspension for external use 12.5 g/100 g: 100 g or 125 g bottle
Marketing Authorization Holder
Ivanovo Pharmaceutical Factory PJSC (Russia)
Dosage Form
|
Cindol | Suspension for external use 12.5 g/100 g: 100 g or 125 g bottle |
Dosage Form, Packaging, and Composition
Suspension for external use white or white with a grayish tint, a heterogeneous suspension with a rapidly settling sediment after shaking.
| 100 g | |
| Zinc oxide | 12.5 g |
Excipients: medical talc – 12.5 g, potato starch – 12.5 g, glycerol – 20 g, ethanol 70% – 20 g, purified water – up to 100 g.
100 g – dark glass bottles (1) – cardboard packs.
100 g – polyethylene terephthalate bottles (1) – cardboard packs.
100 g – polymer jars (1) – cardboard packs.
125 g – dark glass bottles (1) – cardboard packs.
125 g – polyethylene terephthalate bottles (1) – cardboard packs.
125 g – polymer jars (1) – cardboard packs.
100 g – dark glass bottles (30) – cardboard packs (for hospitals).
125 g – dark glass bottles (30) – cardboard packs (for hospitals).
Suspension for external use 12.5%: 50 g, 100 g, 125 g or 200 g bottle 1 pc.
Marketing Authorization Holder
Kirov Pharmaceutical Factory, JSC (Russia)
Dosage Form
|
Cindol | Suspension for external use 12.5%: 50 g, 100 g, 125 g or 200 g bottle 1 pc. |
Dosage Form, Packaging, and Composition
Suspension for external use in the form of a heterogeneous suspension with a rapidly settling sediment of white or white with a grayish tint after shaking.
| 100 g | |
| Zinc oxide | 12.5 g |
Excipients: talc – 12.5 g, potato starch – 12.5 g, glycerol – 20 g, ethanol (ethyl alcohol) 70% – 20 g, purified water – up to 100 g.
50 g – bottles (1) – cardboard packs.
100 g – bottles (1) – cardboard packs.
125 g – bottles (1) – cardboard packs.
200 g – bottles (1) – cardboard packs.
Suspension for external use 12.5 g/100 ml: 100 g or 125 g bottle
Marketing Authorization Holder
Moscow Pharmaceutical Factory CJS (Russia)
Dosage Form
|
Cindol | Suspension for external use 12.5 g/100 ml: 100 g or 125 g bottle |
Dosage Form, Packaging, and Composition
| Suspension for external use | 100 ml |
| Zinc oxide | 12.5 g |
100 g – dark glass bottles (1) – cardboard packs.
100 g – dark glass bottles.
125 g – dark glass bottles (1) – cardboard packs.
125 g – dark glass bottles.
Suspension for external use 12.5%: 10 g, 15 g, 20 g, 25 g, 30 g, 40 g, 50 g, 90 g, 100 g or 125 g bottle
Marketing Authorization Holder
Tula Pharmaceutical Factory, LLC (Russia)
Dosage Form
|
Cindol | Suspension for external use 12.5%: 10 g, 15 g, 20 g, 25 g, 30 g, 40 g, 50 g, 90 g, 100 g or 125 g bottle |
Dosage Form, Packaging, and Composition
Suspension for external use in the form of a heterogeneous suspension of white or white with a grayish tint, with a rapidly settling sediment after shaking.
| 100 g | |
| Zinc oxide | 12.5 g |
Excipients: medical talc – 12.5 g, potato starch – 12.5 g, glycerol – 20 g, ethanol 70% – 20 g, purified water – up to 100 g.
10 g – dark glass bottles (1) with a dropper cap or without – cardboard packs.
15 g – dark glass bottles (1) with a dropper cap or without – cardboard packs.
20 g – dark glass bottles (1) with a dropper cap or without – cardboard packs.
25 g – dark glass bottles (1) with a dropper cap or without – cardboard packs.
30 g – dark glass bottles (1) with a dropper cap or without – cardboard packs.
40 g – dark glass bottles (1) with a dropper cap or without – cardboard packs.
50 g – dark glass bottles (1) with a dropper cap or without – cardboard packs.
90 g – dark glass bottles (1) with a dropper cap or without – cardboard packs.
100 g – dark glass bottles (1) with a dropper cap or without – cardboard packs.
125 g – dark glass bottles (1) with a dropper cap or without – cardboard packs.
Suspension for external use 12.5 g/100 ml: 100 or 125 g bottle
Marketing Authorization Holder
Tula Pharmaceutical Factory, LLC (Russia)
Dosage Form
|
Cindol | Suspension for external use 12.5 g/100 ml: 100 or 125 g bottle |
Dosage Form, Packaging, and Composition
| Suspension for external use | 100 ml |
| Zinc oxide | 12.5 g |
100 g – dark glass bottles.
100 g – dark glass bottles (1) – cardboard packs.
125 g – dark glass bottles.
125 g – dark glass bottles (1) – cardboard packs.
Suspension for external use 12.5 g/100 g: 50 g, 100 g, 125 g or 150 g bottle
Marketing Authorization Holder
Usolye-Sibirskiy Chemical and Pharmaceutical Plant, JSC (Russia)
Dosage Form
|
Cindol | Suspension for external use 12.5 g/100 g: 50 g, 100 g, 125 g or 150 g bottle |
Dosage Form, Packaging, and Composition
Suspension for external use in the form of a heterogeneous suspension with a rapidly settling sediment of white or white with a grayish tint after shaking.
| 100 g | |
| Zinc oxide | 12.5 g |
Excipients: talc – 12.5 g, potato starch – 12.5 g, glycerol – 20 g, ethyl alcohol (ethanol) 70% – 20 g, purified water – up to 100 g.
50 g – orange glass bottles (1) – cardboard packs.
100 g – orange glass bottles (1) – cardboard packs.
125 g – orange glass bottles (1) – cardboard packs.
150 g – orange glass bottles (1) – cardboard packs.
Suspension for external use 12.5 g/100 g: 10 g, 15 g, 20 g, 25 g, 30 g, 40 g, 50 g, 90 g, 100 g or 125 g bottle
Marketing Authorization Holder
Formula-FR, LLC (Russia)
Manufactured By
Tula Pharmaceutical Factory, LLC (Russia)
Dosage Form
|
Cindol | Suspension for external use 12.5 g/100 g: 10 g, 15 g, 20 g, 25 g, 30 g, 40 g, 50 g, 90 g, 100 g or 125 g bottle |
Dosage Form, Packaging, and Composition
Suspension for external use in the form of a heterogeneous suspension with a rapidly settling sediment of white or white with a grayish tint after shaking.
| 100 g | |
| Zinc oxide | 12.5 g |
Excipients: talc – 12.5 g, potato starch – 12.5 g, glycerol – 20 g, ethanol 70% – 20 g, purified water – up to 100 g.
10 g – orange glass bottles (1) – cardboard packs.
15 g – orange glass bottles (1) – cardboard packs.
20 g – orange glass bottles (1) – cardboard packs.
25 g – orange glass bottles (1) – cardboard packs.
30 g – orange glass bottles (1) – cardboard packs.
40 g – orange glass bottles (1) – cardboard packs.
50 g – orange glass bottles (1) – cardboard packs.
90 g – orange glass bottles (1) – cardboard packs.
100 g – orange glass bottles (1) – cardboard packs.
125 g – orange glass bottles (1) – cardboard packs.
Suspension for topical application 12.5%: fl. 100 g or 125 g, bot. 100 g or 125 g
Marketing Authorization Holder
YUGPHARM, LLC (Russia)
Dosage Form
|
Cindol | Suspension for topical application 12.5%: fl. 100 g or 125 g, bot. 100 g or 125 g |
Dosage Form, Packaging, and Composition
Suspension for external use in the form of a heterogeneous suspension with a rapidly settling sediment of white or white with a grayish tint after shaking.
| 100 g | |
| Zinc oxide | 12.5 g |
Excipients: talc – 12.5 g, corn starch – 12.5 g, glycerol – 20 g, ethanol 70% – 20 g, purified water – up to 100 g.
100 g – bottles (1) – cardboard packs.
125 g – bottles (1) – cardboard packs.
100 g – bottles (1) – cardboard packs.
125 g – bottles (1) – cardboard packs.
Suspension for topical application 12.5 g/100 ml: fl. or dropper bot. 50 g, 100 g or 125 g
Marketing Authorization Holder
Yaroslavl Pharmaceutical Factory, CJSC (Russia)
Dosage Form
|
Cindol | Suspension for topical application 12.5 g/100 ml: fl. or dropper bot. 50 g, 100 g or 125 g |
Dosage Form, Packaging, and Composition
Suspension for external use in the form of a heterogeneous suspension with a rapidly settling sediment of white or white with a grayish tint after shaking.
| 100 g | |
| Zinc oxide | 12.5 g |
Excipients: talc – 12.5 g, potato starch – 12.5 g, glycerol (glycerin) – 20 g, ethanol (ethyl alcohol) 70% – 20 g, purified water – up to 100 g.
50 g – bottles (1) – carton packs.
100 g – bottles (1) – carton packs.
125 g – bottles (1) – carton packs.
50 g – dropper bottles (1) – carton packs.
100 g – dropper bottles (1) – carton packs.
125 g – dropper bottles (1) – carton packs.
![Cindol [Suspension] 1](https://www.medixlife.com/wp-content/uploads/Medixlife_favi_512.png "Cindol [Suspension] 2")